↓ Skip to main content

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands

Overview of attention for article published in BMC Infectious Diseases, February 2012
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands
Published in
BMC Infectious Diseases, February 2012
DOI 10.1186/1471-2334-12-35
Pubmed ID
Authors

Patricia Kaaijk, Arie van der Ende, Guy Berbers, Germie PJM van den Dobbelsteen, Nynke Y Rots

Abstract

The first meningococcal serogroup C (MenC) conjugate vaccine was licensed in 1999 and introduced in the United Kingdom. Countries that have implemented the MenC vaccine since then in their national immunisation programmes use different schedules. Nevertheless, all involved countries seem to experience substantial declines in the incidence of MenC disease.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
United States 1 3%
Unknown 34 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 19%
Researcher 6 17%
Student > Ph. D. Student 6 17%
Other 5 14%
Student > Bachelor 3 8%
Other 1 3%
Unknown 8 22%
Readers by discipline Count As %
Medicine and Dentistry 13 36%
Agricultural and Biological Sciences 4 11%
Biochemistry, Genetics and Molecular Biology 2 6%
Nursing and Health Professions 1 3%
Mathematics 1 3%
Other 4 11%
Unknown 11 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 February 2012.
All research outputs
#18,304,230
of 22,662,201 outputs
Outputs from BMC Infectious Diseases
#5,552
of 7,635 outputs
Outputs of similar age
#197,171
of 247,685 outputs
Outputs of similar age from BMC Infectious Diseases
#55
of 72 outputs
Altmetric has tracked 22,662,201 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,635 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 247,685 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.